SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    William E Berger, MP29-02 for the treatment of seasonal allergic rhinitis: a review of clinical pharmacology, efficacy and safety, Expert Review of Clinical Immunology, 2013, 9, 9, 803

    CrossRef

  2. 2
    Paul H. Ratner, Frank Hampel, Julius Van Bavel, N.J. Amar, Pramila Daftary, William Wheeler, Harry Sacks, Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis, Annals of Allergy, Asthma & Immunology, 2008, 100, 1, 74

    CrossRef

  3. 3
    Anjuli S Nayak, Mometasone furoate monohydrate nasal spray for the treatment of nasal congestion in allergic rhinitis, Expert Review of Clinical Immunology, 2008, 4, 2, 143

    CrossRef

  4. 4
    Jonathan A. Bernstein, Azelastine hydrochloride:a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability, Current Medical Research and Opinion, 2007, 23, 10, 2441

    CrossRef

  5. 5
    Magnus Korsgren, Morgan Andersson, Olof Borgå, Lars Larsson, Marie Aldén-Raboisson, Ulf Malmqvist, Lennart Greiff, Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis, Annals of Allergy, Asthma & Immunology, 2007, 98, 4, 316

    CrossRef

  6. 6
    William Storms, Barbara Yawn, Leonard Fromer, Therapeutic options for reducing sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis, Current Medical Research and Opinion, 2007, 23, 9, 2135

    CrossRef

  7. 7
    William Berger, Frank Hampel, Jonathan Bernstein, Shailen Shah, Harry Sacks, Eli O. Meltzer, Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis, Annals of Allergy, Asthma & Immunology, 2006, 97, 3, 375

    CrossRef

  8. 8
    Phil Lieberman, Michael A. Kaliner, William J. Wheeler, Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis*, Current Medical Research and Opinion, 2005, 21, 4, 611

    CrossRef

  9. 9
    Craig F. LaForce, Jonathan Corren, William J. Wheeler, William E. Berger, Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine, Annals of Allergy, Asthma & Immunology, 2004, 93, 2, 154

    CrossRef

  10. 10
    Stephen M Boorstein, Henry J Henk, Victor M Elner, Atopy: a patient-specific risk factor for diffuse lamellar keratitis, Ophthalmology, 2003, 110, 1, 131

    CrossRef

  11. 11
    Morgan Andersson, Emerging treatments forallergic rhinitis, Expert Opinion on Emerging Drugs, 2003, 8, 1, 63

    CrossRef

  12. 12
    William E. Berger, Overview of allergic rhinitis, Annals of Allergy, Asthma & Immunology, 2003, 90, 6, 7

    CrossRef

  13. 13
    G. W. Canonica, G. Ciprandi, U. Petzold, C. Kolb, B. Ellers-Lenz, R. Hermann, Topical azelastine in perennial allergic conjunctivitis, Current Medical Research and Opinion, 2003, 19, 4, 321

    CrossRef

  14. 14
    Leonard Bielory, Role of antihistamines in ocular allergy, The American Journal of Medicine, 2002, 113, 9, 34

    CrossRef

  15. 15
    William E. Berger, Allergic rhinitis in children, Current Allergy and Asthma Reports, 2001, 1, 6, 498

    CrossRef

  16. 16
    R. KAUPPINEN, V. VILKKA, H. SINTONEN, T. KLAUKKA, H. TUKIAINEN, Long-term economic evaluation of intensive patient education during the first treatment year in newly diagnosed adult asthma, Respiratory Medicine, 2001, 95, 1, 56

    CrossRef

  17. 17
    P. Van Cauwenberge, C. Bachert , G. Passalacqua , J. Bousquet , G. W. Canonica , S. R. Durham , W. J. Fokkens , P. H. Howarth , V. Lund , H.-J. Malling , N. Mygind , D. Passali , G. K. Scadding , D.-Y. Wang , Consensus statement on the treatment of allergic rhinitis, Allergy, 2000, 55, 2
  18. 18
    Närhi, Airaksinen, Tanskanen, Erlund, Therapeutic outcomes monitoring by community pharmacists for improving clinical outcomes in asthma, Journal of Clinical Pharmacy and Therapeutics, 2000, 25, 3
  19. 19
    C. Ortolani, C. Mirone, A. Foresi, C. Leone, G. Di Lorenzo, G. Bagnato, F. Bonifazi, N. Crimi, L. Emmi, M. Prandini, G.E. Senna, A. Tursi, P. Fina, R. Testi, A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis, Allergy, 1999, 54, 11
  20. 20
    Ignasi Cardelús, Francisca Antón, Jorge Beleta, José M Palacios, Anticholinergic effects of desloratadine, the major metabolite of loratadine, in rabbit and guinea-pig iris smooth muscle, European Journal of Pharmacology, 1999, 374, 2, 249

    CrossRef

  21. 21
    Robert Naclerio, Clinical manifestations of the release of histamine and other inflammatory mediators, Journal of Allergy and Clinical Immunology, 1999, 103, 3, S382

    CrossRef

  22. 22
    Di Lorenzo, Gervasi, Drago, Esposito Pellitteri, Di Salvo, Cosentino, Potestio, Colombo, Candore, Mansueto, Caruso, Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics, Clinical & Experimental Allergy, 1999, 29, 10
  23. 23
    Melanie Hingorani, Drug therapy for ocular allergy, Expert Opinion on Investigational Drugs, 1998, 7, 1, 27

    CrossRef

  24. 24
    Paul Cauwenberge, Deyun Wang, Antihistamines and nasal blockage, Allergy, 1997, 52,
  25. 25
    Julie B Sedgwick, William W Busse, Inhibitory Effect of Cetirizine on Cytokine-Enhanced in Vitro Eosinophil Survival, Annals of Allergy, Asthma & Immunology, 1997, 78, 6, 581

    CrossRef

  26. 26
    Christian MöIIer, Niels Mygind, Nasal blockage in chldren with non-infectious rhnitis: consequences and treatment, Allergy, 1997, 52,